Bioanalysis Zone

PerkinElmer: technology available in the fight against COVID-19

0

PerkinElmer, Inc. (MA, USA) have described their detection, workflow and research solutions being used by their global customers to combat COVID-19. Their customers include speciality and reference diagnostic labs, academia and governmental research institutes, all working to find solutions to the current pandemic. Their solutions have also been employed by research institutions across the globe, including laboratories associated with Baylor University (TX, USA), Medical College of Georgia (GA, USA), Rutgers University (NJ, USA), University of Buffalo (NY, USA) and institutes in Brazil.

PerkinElmer offer a range of SARS-CoV-2 technology including RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow-based serology testing.

Serological

Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN (Lübeck, Germany; a PerkinElmer company), have recently received CE mark and can now be applied to COVID-19 diagnostics. PerkinElmer’s immunoglobulin class G assay has also received US FDA Emergency Use Authorization (EUA) which is reportedly the first incidence of the FDA taking an active interest in validating assays. These tests may help determine how quickly antibodies to the SARS-CoV-2 virus can be made, which could assist identify people who have developed immunity.

PerkinElmer’s GSP®/DELFIA® Anti-SARS-CoV-2 IgG kit is a fully automated serological assay using DBS samples and has also received CE Mark. The kit is DELFIA®-based (dissociation-enhanced lanthanide fluorescence immunoassay) and is run on the GSP® analyzer, a fully automated and high throughput system used traditionally with newborn screening.

In other news, Beaumont Health Research Institute (MI, USA) is launching America’s largest serological testing study using two PerkinElmer EUROLabWorkstations and EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits.

The Coronavirus Nucleic Acid Detection Kit by PerkinElmer has recently received FDA EUA and is certified under Clinical Laboratory Improvement Amendments to be used in clinical laboratories to detect SARS-CoV-2.  EURORealTime SARS-COV-2 has received CE mark and FDA EUA and PerkinElmer have also received an FDA EUA amendment to add their chemagic™ Viral DNA/ RNA 300 Kit H96 and chemagic™ 360 instrument to a new Coronavirus RT-PCR test.

In an effort to increase transparency, PerkinElmer are live streaming their turnaround times for delivery of SARS-CoV-2 tests. Through this they are also hoping to assist testing centers maintain their maximum capacity and enable laboratories to rapidly adjust to public health needs.

Workflows

PerkinElmer have broad range of total workflow solutions that are reportedly able to assist the rapid processing of clinical diagnostics. In terms of COVID-19, they report their automated SARS-CoV-2 PCR detection workflow solutions can be used with the PerkinElmer New Coronavirus RT-PCR test or any other 2019-nCoV PCR assay.  In particular, the JANUS® G3 workstation is able to standardize nucleic acid isolation and PCR assay set-up to alleviate high throughout demands and reduce manual tasks, whilst their LabChip® GX Touch™ Nucleic Acid Analyzer can provide DNA and RNA quantitation and sizing using automated capillary electrophoresis separation.

Critical solutions for research

For pharmaceutical laboratories investigating new drugs, vaccines or potential existing drugs that can be repurposed for COVID-19, PerkinElmer is reporting to be able to provide a variety of instruments, reagents, softwares and services. For example, Signals™ Medical Review and TIBCO Spotfire® can provide informatic solutions from vast amounts of drug, vaccine or clinical trial data, where as their Opera Phenix® and Operetta® CLS™ platforms can provide high content cellular images to facilitate understanding of viral infections and immune host responses.

PerkinElmer’s EnVision® and VICTOR™ Nivo® with Alpha, DELFIA®, and HTRF® biomarker reagent kits are also available. These provide detection and characterization of viral proteins and host immune markers. Their QSight®, LAMBDA®, and Spectrum™ series instruments are available for preclinical development to analyze drug metabolism and protein characterization.

In regards to the increased global demand for hand sanitizers during the pandemic, PerkinElmer’s Spectrum Two™+ spectrometer is able to provide a fast reliable method for production laboratories to assist them determine the ethanol and isopropanol content of hand sanitizers according to the World Health Organization and US FDA-approved formulations.

Finally, OneSource® service teams from PerkinElmer continue to help pharmaceutical companies maintain critical laboratory instruments and software, especially during these challenging times.

Assisting communities

In their continued dedication to helping fight COVID-19, PerkinElmer are organizing donations of instruments and critical reagent kits to screen and diagnose the disease in critical locations across the globe. Currently, they have reportedly donated over $1 million (USD) worth of instrumentation.


Source: www.ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-releases-new-dried-blood-spot-based-covid-19 

COVID-19 hub

Share:

Leave A Comment